32nd World Congress of the World Society of Cardiovascular and Thoracic Surgeons in Barcelona, 5.-7. September 2024
Dr. Sarikouch is going to present “Long-term results of modern homografts” within the session "Cardiovascular Tissue Banking at the WSCTS in Barcelona, ”. Decellularized pulmonary and aortic homografts have been studied in prospective European-wide multi-center settings.
https://academic.oup.com/ejcts/article/62/5/ezac219/6568944
https://academic.oup.com/ejcts/article/65/4/ezae121/7635581
EACTS 2nd Innovation Summit, 18-20. April 2024, Paris
The 2nd EACTS Innovation Summit was held at the Chateau Les Pres d`Ecoublay near Paris this April. Sessions were dedicated to the “Future of Robotic Surgery”, “Extracorporal Circulation”, “Artificial Intelligence for Cardiothoracic Surgery” and the “Heart valve of the future”
https://www.eacts.org/our-community/news-hub/eacts-hosts-paris-innovation-summit/
Ross-Symposium 2025 in Lübeck/Germany - Role of decellularized pulmonary homografts for paediatric Ross patients
The Ross autograft operation for aortic valve replacement requires pulmonary valve replacement. This is usually performed with a homograft. Dr. Sarikouch from Hannover Medical School presented the current evidence for decellularized pulmonary homografts for pulmonary valve replacement in the Ross operation for adults and children.
https://www.uksh.de/Service/Veranstaltungen+am+UKSH-event-Herzchirurgie_Luebeck.de.4862.html
This project has received funding from the European Union’s Seventh Framework Programme (FP7/2007-20013) under Grant Agreement Number 278453.
ClinicalTrials.gov identifier: NCT02035540
